101 related articles for article (PubMed ID: 21839267)
1. Unresponsiveness to a kidney graft after a fully matched allogenic bone marrow transplantation combined with low-dose tacrolimus therapy: a case report.
Álvarez S; Boltansky A; Alfaro J; Sepúlveda L; Ursu M; Innocenti G; Carvajal D; Villamizar G; Hurtado M; Vukusich A
Transplant Proc; 2011; 43(6):2344-6. PubMed ID: 21839267
[TBL] [Abstract][Full Text] [Related]
2. Successful renal transplantation following prior bone marrow transplantation in pediatric patients.
Thomas SE; Hutchinson RJ; DebRoy M; Magee JC
Pediatr Transplant; 2004 Oct; 8(5):507-12. PubMed ID: 15367289
[TBL] [Abstract][Full Text] [Related]
3. A case of thrombotic thrombocytopenic purpura following allogeneic bone marrow transplantation.
Tschuchnigg M; Bradstock KF; Koutts J; Stewart J; Enno A; Seldon M
Bone Marrow Transplant; 1990 Jan; 5(1):61-3. PubMed ID: 2297591
[TBL] [Abstract][Full Text] [Related]
4. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
Mehta J; Powles R; Singhal S; Iveson T; Treleaven J; Catovsky D
Bone Marrow Transplant; 1996 Mar; 17(3):371-5. PubMed ID: 8704689
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis.
Paquette RL; Tran L; Landaw EM
Bone Marrow Transplant; 1998 Aug; 22(4):351-7. PubMed ID: 9722070
[TBL] [Abstract][Full Text] [Related]
6. Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation.
Bylund KC; Giampoli E; Singh D; Doerr T; Sahasrabudhe D; Liesveld J; Constine LS
Cancer Invest; 2008 Jul; 26(6):638-41. PubMed ID: 18584356
[TBL] [Abstract][Full Text] [Related]
7. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
[TBL] [Abstract][Full Text] [Related]
8. Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease.
Nishida T; Hamaguchi M; Hirabayashi N; Haneda M; Terakura S; Atsuta Y; Imagama S; Kanie T; Murata M; Taji H; Suzuki R; Morishita Y; Kodera Y
Bone Marrow Transplant; 2004 Jun; 33(11):1143-50. PubMed ID: 15077133
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of renal failure caused by multiple myeloma with HLA-identical living kidney and bone marrow transplantation: a case report.
Wagner L; Lengyel L; Mikala G; Reményi P; Piros L; Csomor J; Fábry L; Tordai A; Langer RM; Masszi T
Transplant Proc; 2013; 45(10):3705-7. PubMed ID: 24315003
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
Mehta J; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Middleton G; Eisen T; Singhal S
Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189
[TBL] [Abstract][Full Text] [Related]
11. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
Devine SM; Geller RB; Lin LB; Dix SP; Holland HK; Maurer D; O'Toole K; Keller J; Connaghan DG; Heffner LT; Hillyer CD; Rodey GE; Winton EF; Maher RM; Fitzsimmons WE; Wingard JR
Biol Blood Marrow Transplant; 1997 Apr; 3(1):25-33. PubMed ID: 9209738
[TBL] [Abstract][Full Text] [Related]
12. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
[TBL] [Abstract][Full Text] [Related]
13. Ten Year Follow-up for a Patient Postmatched Unrelated Donor Bone Marrow Transplant Followed by Same Donor Kidney Transplant: Normal Renal Function Without Immunosuppression.
Younge J; Duffner UA; Bunchman T; Abdel-Mageed A
Transplantation; 2015 Sep; 99(9):e162. PubMed ID: 26308423
[No Abstract] [Full Text] [Related]
14. Thrombotic thrombocytopenic purpura: a rare late complication of allogeneic bone marrow transplantation.
Pucci G; Martino M; Morabito F; Iacopino P; Arcese W; Iori AP; Lombardo VT; L'Abbate A; Santostefano M; Nobile F
Haematologica; 1994; 79(4):371-3. PubMed ID: 7806094
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT.
Kist-van Holthe JE; van Zwet JM; Brand R; van Weel MH; Vossen JM; van der Heijden AJ
Bone Marrow Transplant; 1998 Sep; 22(6):559-64. PubMed ID: 9758343
[TBL] [Abstract][Full Text] [Related]
16. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of immunosuppression for prevention of kidney graft rejection after receiving a bone marrow transplant from the same HLA identical sibling donor.
Gajewski JL; Ippoliti C; Ma Y; Champlin R
Am J Hematol; 2002 Dec; 71(4):311-3. PubMed ID: 12447962
[TBL] [Abstract][Full Text] [Related]
18. [Gastroenterologic findings in graft versus host disease after allogenic bone marrow transplantation].
Kreisel W; Fauser AA; Dölken G; Herbst EW
Z Gastroenterol; 1991 Jun; 29(6):289-93. PubMed ID: 1926962
[TBL] [Abstract][Full Text] [Related]
19. Severe acute graft-versus-host disease occurring after syngeneic BMT for AML in a patient not given prior cyclosporin A therapy.
Hwang WY; Goh YT; Tan CH; How GF; Tan HC
Bone Marrow Transplant; 2000 Jan; 25(2):205-7. PubMed ID: 10673682
[TBL] [Abstract][Full Text] [Related]
20. Graft-versus-host disease following bone marrow transplantation: clinical feature and diagnosis.
Kikuta A; Suzuki H
Fukushima J Med Sci; 1993 Dec; 39(2):95-9. PubMed ID: 7927140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
